Susquehanna International Group’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.79M Buy
353,298
+112,123
+46% +$567K ﹤0.01% 2427
2025
Q1
$1.36M Sell
241,175
-53,268
-18% -$301K ﹤0.01% 2850
2024
Q4
$2.56M Buy
294,443
+158,988
+117% +$1.38M ﹤0.01% 1683
2024
Q3
$939K Buy
+135,455
New +$939K ﹤0.01% 2758
2024
Q2
Hold
0
5727